Dapagliflozin update

New Update: Dapagliflozin is now approved for treatment of heart failure in patients with reduced ejection fraction(HFrEF) The approval follows positive results from the landmark Phase III DAPA-HF trial.

3 Likes

LikeAnswersShare
Yes it is now well advocated in cases of diabetic as well as nondiabetic heart failure with low ejection fraction
Yes sir
0
Thanks for sharing this informative post
Welcome dr
0
Thank u sir for the info
Welcome dr
0
Thanks for update
Welcum dr
0
Informative
Welcum dr
0
Nice update
Welcum dr
1
Informative
Welcum
0